Home›Earnings›Previews›Tilray earnings on Oct. 8 seen as a cannabis sector ba…

Tilray earnings on Oct. 8 seen as a cannabis sector barometer

Curaleaf raised its hostile bid for Aurora Cannabis to $5 per share amid a shift in U.S. policy that moved state-regulated medical cannabis into Schedule III.

Reported · Written up by our desk · Previews

Curaleaf has increased its hostile bid for Aurora Cannabis to $5 per share as consolidation heats up across the U.S. cannabis industry, according to MarketBeat Ratings.

The move is tied to federal regulatory change, including a Department of Justice order issued in April 2026 that placed state-regulated medical cannabis into Schedule III, which MarketBeat Ratings frames as a catalyst for multiple expansion and dealmaking.

With Schedule III in effect, the article says Schedule I Section 280E restrictions are lifted, allowing cannabis businesses to deduct ordinary operating expenses such as payroll, rent, and marketing rather than paying taxes on gross profit.

MarketBeat Ratings also points to Tilray’s Oct. 8 earnings as a key readout for how the sector is digesting the policy shift and its impact on operator performance.

More like this

Sources